Nextgen Bioscience Co., Ltd.
PrivateLast Round
VC Round
Jul 31, 2023
Total Funding Raised
$26.06M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Nextgen Bioscience Co., Ltd. is a biotechnology company that develops therapeutics for autoimmune and fibrotic diseases using its proprietary AI-based drug discovery platform, Fibrain™.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nextgen Bioscience Co., Ltd. Comparables
Compare Nextgen Bioscience Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Standigm | 80% | |
| Oncocross Co., Ltd. | 77% | |
| SyntekaBio Inc | 77% |
Nextgen Bioscience Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 31, 2023 | ||||
| Series B Extension | Dec 1, 2022 | ||||
| Strategic | Dec 1, 2021 | ||||
| Series B | Jul 1, 2020 | ||||
| Series A | Jul 1, 2019 | ||||
Pre Seed | Dec 1, 2018 |
Nextgen Bioscience Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DSC Investment | Pre Seed, Series B, Series A |
| Korea Investment Partners | Pre Seed, Series B, Series A |
| Korea Development Bank | Series B |
| Korea Investment Trust Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 45% MoM.
- Jan 1, 2026
Monthly visitors increased 39% MoM.
Nextgen Bioscience Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nextgen Bioscience Co., Ltd.'s valuation, stock price, and market status.
Is Nextgen Bioscience Co., Ltd. a public or private company?
Nextgen Bioscience Co., Ltd. is a private company.
What is the current stock price of Nextgen Bioscience Co., Ltd.?
Nextgen Bioscience Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Nextgen Bioscience Co., Ltd. worth (valuation)?
Valuation information for Nextgen Bioscience Co., Ltd. is not publicly available.
Can I buy Nextgen Bioscience Co., Ltd. stock?
Nextgen Bioscience Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nextgen Bioscience Co., Ltd.'s last funding round?
Nextgen Bioscience Co., Ltd.'s most recent funding round was VC Round on July 31, 2023.
Who are the main investors in Nextgen Bioscience Co., Ltd.?
Key investors in Nextgen Bioscience Co., Ltd. include DSC Investment, Korea Investment Partners, Korea Development Bank, Korea Investment Trust Management.
Will Nextgen Bioscience Co., Ltd. IPO soon?
No public IPO plans have been announced for Nextgen Bioscience Co., Ltd..
How can I track Nextgen Bioscience Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nextgen Bioscience Co., Ltd.'s secondary market activity and sign up for updates.